Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:15PM EDT. Market open.
| Previous close | 1.9200 |
| Open | 1.9200 |
| Bid | 1.8700 x 200 |
| Ask | 1.8800 x 200 |
| Day's range | 1.8707 - 1.9493 |
| 52-week range | 1.2500 - 14.5500 |
| Volume | |
| Avg. volume | 10,922,695 |
| Market cap | 510.667M |
| Beta (5Y monthly) | 1.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Pacific Biosciences of California First Quarter 2024 Earnings: Misses Expectations
Pacific Biosciences of California ( NASDAQ:PACB ) First Quarter 2024 Results Key Financial Results Revenue: US$38.8m...
- Insider Monkey
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript May 9, 2024 Pacific Biosciences of California, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the PacBio First Quarter 2024 Earnings Conference Call. All […]
- GuruFocus.com
Pacific Biosciences of California Inc (PACB) Q1 2024 Earnings: Narrowing Losses but Misses ...
Detailed Analysis of PACB's Financial Performance and Strategic Adjustments
© 2024 Yahoo. All rights reserved.